Digital therapeutics: What are they, and where do they fit into pharmacy and medical benefits? Learn more in this blog post from AMCP CEO Susan A. Cantrell, RPh, CAE.
AMCP CEO Blog: With PA so often misunderstood, perhaps we need to do a better job of explaining this tool to the general public. For example, we might provide an example of how PAs are applied to opioids as additional safeguards to ensure their appropriate use. Or how a PA might be applied to botulinum toxin to ensure the prescription is for medical, rather than cosmetic, purposes.
AMCP CEO Blog: AMCP’s roughly 8,000 members work diligently every day to improve patient care through the optimized use of medicines. As an organization, we also take a leading role in developing improvements to the overall delivery of care, which is no easy task given the size and complexity of our health care system.
AMCP CEO Blog: We live in an interconnected world where the marketplace for all things is global. But we must also make sure the global system works for the benefit of the patients we serve. That includes taking steps to ensure the long-term stability and integrity of our critical pharmaceutical supply chain.
AMCP CEO Blog: PA is a crucial but often-misunderstood utilization management tool in the pharmacy benefit space.
AMCP CEO Address: AMCP CEO Susan A. Cantrell, RPh, CAE addressed the AMCP 2019 Annual Meeting on March 26, laying out how AMCP is prepared to meet the challenges of today’s complex health care system. The following is a lightly edited transcript of that address.
AMCP CEO Blog: Thoughts on Digital Therapeutics. These therapeutics offer the potential to revolutionize population health management and help patients live healthier lives.
AMCP CEO Address: AMCP CEO Susan A. Cantrell, RPh, CAE addressed attendees at AMCP Nexus 2018 in Orlando. This is a lightly edited transcript of that address.
AMCP CEO Blog: As managed care pharmacy professionals, we work to improve the lives of millions of people. But we also must never forget that behind these large numbers are individual patients.
AMCP CEO Blog: A new article in Health Affairs (http://bit.ly/2BQlgo9) highlights the challenges that many health plans and payers face as spending on pharmaceuticals continues to rise. The report, which looked at total health care spending at Harvard Pilgrim Health Care (HPHC) from 2011 and 2016, found that spending on pharmaceuticals had increased to a full 25% of all dollars spent.
AMCP CEO Blog: By now, it’s virtually an article of faith that the costs of pharmaceuticals are too high (and, by-the-way, so are costs of hospitalizations, MRIs, ambulance rides and many other health care interventions).
AMCP CEO Blog: This truism lies at the heart of much of what managed care pharmacy does. AMCP members and their organizations have long championed the use of preventive-care services to achieve better health outcomes and lower overall health care costs.